The Effect of Cranial Electrotherapy Stimulation on the Cognition, Anxiety, Depression and Sleep Quality of Chronic Psychiatric Patients
1 other identifier
interventional
92
1 country
1
Brief Summary
- 1.Research background Residents of nursing homes are chronically ill patients who are placed in long-term homes. Studies have shown that most residents live alone and are prone to loneliness, loss, depression, and anxiety (Lapane et al., 2022). Cranial electrostimulation (CES) can improve anxiety, depression, and sleep, but there are few studies on the cognitive status of patients with chronic mental illness.
- 2.Research purpose This study uses cranial microcurrent stimulation (CES) to improve cognition, anxiety, depression, sleep and other conditions in patients with chronic mental illness, with the aim of improving their quality of life.
- 3.Screening criteria for respondents 3.1 Inclusion criteria (Those who meet the following criteria are suitable to participate in this study)
- 4.The study was conducted at the Psychiatric Center
- 5.A total of 92 people were admitted, and they were randomly grouped.
- 6.This study is a interventional study. Before the intervention, a questionnaire must be filled out, which takes about 30 minutes. Then CES is performed 5 times a week, each time for 40 minutes. After completion, the questionnaire must be filled out again. After 3 months of follow-up, another questionnaire test will be conducted.
- 7.Possible discomfort and treatment methods During the CES intervention, if you feel dizzy, skin allergies, ear discomfort, or any discomfort, the intervention will be stopped immediately and the medical team will evaluate and treat you.
- 8.Expected benefits of the study This study uses cranial electrostimulation (CES) to improve cognition, anxiety, depression, sleep and other conditions in patients with chronic mental illness, with the aim of improving their quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2025
CompletedStudy Start
First participant enrolled
April 20, 2025
CompletedFirst Posted
Study publicly available on registry
May 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMay 13, 2025
May 1, 2025
5 months
April 17, 2025
May 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
sleep
The Pittsburgh Sleep Quality Inventory (PSQI) is a self-administered questionnaire developed by Buysse et al. (1989). They felt that sleep quality has become an important issue in clinical practice, so they referred to the existing sleep quality scale and developed it into a self-administered questionnaire that can explore sleep conditions in the past month. This scale can be used as a self-assessment tool to measure sleep quality. Its content covers seven sub-concepts, including self-assessed sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbance, use of sleeping pills, and daytime function.
"From enrollment to the end of treatment at 12 weeks"
Depression
This study used the Taiwanese Depression Scale (TDS) revised by scholar Yu (2011). The purpose of this scale is to screen cases with depressive symptoms. It has a total of 18 questions, and each question is divided into 0 points (no or very few symptoms), 1 point (sometimes there are symptoms), 2 points (often there are symptoms), and 3 points (often or always there are symptoms) according to the severity. The total score ranges from 0 to 54 points. The higher the score, the more severe the depressive symptoms (Yu, Huang, and Liu, 2011). Lee et al. conducted a reliability and validity analysis on 107 community residents using this scale and found that the internal consistency Cronbach's alpha coefficient was 0.90. The DSM III-R (Edition, Revised) was used as the diagnostic standard. After the receiver operating characteristic curve (ROC) analysis, it was found that the total score of 19 points was the best cut-off point for diagnosing depression, with a sensitivity of 0.89 and a speci
"From enrollment to the end of treatment at 12weeks"
Secondary Outcomes (2)
cognition
"From enrollment to the end of treatment at 12 weeks"
anxiety
"From enrollment to the end of treatment at 12 weeks"
Study Arms (2)
experimental group
EXPERIMENTALthe experimental group was provided with 5 CES participations per week, each time for 40 minutes, for a total of 12 weeks
control group
NO INTERVENTIONInterventions
Currently, most CES intervention studies are applied to the general public, and a few studies focus on athletic performance. There are no related studies on residents of psychiatric nursing homes, nor are there any research designs for improving cognitive impairment. Therefore, this study explores the use of CES programs to improve the cognition, anxiety, depression, and other conditions of residents of psychiatric care homes, with the goal of improving their quality of life.
Eligibility Criteria
You may qualify if:
- \. Chronic mental illness patients, 2. Mini-Mental State Examination (MMSE) ≥ 16 points, 3. Education level is junior high school graduates or above, 4. Appropriate oral expression ability, 5. Those who can complete the research consent form, 6. Those who are willing to participate in this study
You may not qualify if:
- \. Those with obvious risk of violence or suicide 2. People with cognitive impairment who have been diagnosed with mental retardation or autism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Liu Hsing Yulead
Study Sites (1)
Tsaotun Psychiatric Center, MOHW
Nantou City, 542, Taiwan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- nurse
Study Record Dates
First Submitted
April 17, 2025
First Posted
May 13, 2025
Study Start
April 20, 2025
Primary Completion
September 30, 2025
Study Completion
December 31, 2025
Last Updated
May 13, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share